Encouraging the prescribing of SGLT2i and GLP-1RA medications to reduce cardiovascular and renal risk in patients with type 2 diabetes: rationale and design of a randomized controlled trial.
Nancy Haff
1, 2
,
Daniel M. Horn
2, 3, 4
,
Gauri Bhatkhande
1, 5
,
Meekang Sung
1
,
Caitlin Colling
2, 3
,
Wendy Wood
6
,
Ted Robertson
7, 8
,
Daniel Gaposchkin
2, 3
,
Leigh Simmons
2, 3
,
Judy Yang
2, 3
,
James Yeh
2, 3
,
Katherine L. Crum
1
,
Kaitlin E. Hanken
1
,
Julie C. Lauffenburger
1, 2
,
Niteesh K. Choudhry
1, 2
4
Medical Director of Devoted Health, Waltham, MA
7
Ideas42, New York, NY
|
Publication type: Journal Article
Publication date: 2025-07-01
scimago Q1
wos Q2
SJR: 2.039
CiteScore: 7.1
Impact factor: 3.5
ISSN: 00028703, 10976744
Found
Nothing found, try to update filter.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
0
Total citations:
0
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
Haff N. et al. Encouraging the prescribing of SGLT2i and GLP-1RA medications to reduce cardiovascular and renal risk in patients with type 2 diabetes: rationale and design of a randomized controlled trial. // American Heart Journal. 2025. Vol. 285. pp. 39-51.
GOST all authors (up to 50)
Copy
Haff N., Horn D. M., Bhatkhande G., Sung M., Colling C., Wood W., Robertson T., Gaposchkin D., Simmons L., Yang J., Yeh J., Crum K. L., Hanken K. E., Lauffenburger J. C., Choudhry N. K. Encouraging the prescribing of SGLT2i and GLP-1RA medications to reduce cardiovascular and renal risk in patients with type 2 diabetes: rationale and design of a randomized controlled trial. // American Heart Journal. 2025. Vol. 285. pp. 39-51.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.ahj.2025.02.007
UR - https://linkinghub.elsevier.com/retrieve/pii/S0002870325000389
TI - Encouraging the prescribing of SGLT2i and GLP-1RA medications to reduce cardiovascular and renal risk in patients with type 2 diabetes: rationale and design of a randomized controlled trial.
T2 - American Heart Journal
AU - Haff, Nancy
AU - Horn, Daniel M.
AU - Bhatkhande, Gauri
AU - Sung, Meekang
AU - Colling, Caitlin
AU - Wood, Wendy
AU - Robertson, Ted
AU - Gaposchkin, Daniel
AU - Simmons, Leigh
AU - Yang, Judy
AU - Yeh, James
AU - Crum, Katherine L.
AU - Hanken, Kaitlin E.
AU - Lauffenburger, Julie C.
AU - Choudhry, Niteesh K.
PY - 2025
DA - 2025/07/01
PB - Elsevier
SP - 39-51
VL - 285
SN - 0002-8703
SN - 1097-6744
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2025_Haff,
author = {Nancy Haff and Daniel M. Horn and Gauri Bhatkhande and Meekang Sung and Caitlin Colling and Wendy Wood and Ted Robertson and Daniel Gaposchkin and Leigh Simmons and Judy Yang and James Yeh and Katherine L. Crum and Kaitlin E. Hanken and Julie C. Lauffenburger and Niteesh K. Choudhry},
title = {Encouraging the prescribing of SGLT2i and GLP-1RA medications to reduce cardiovascular and renal risk in patients with type 2 diabetes: rationale and design of a randomized controlled trial.},
journal = {American Heart Journal},
year = {2025},
volume = {285},
publisher = {Elsevier},
month = {jul},
url = {https://linkinghub.elsevier.com/retrieve/pii/S0002870325000389},
pages = {39--51},
doi = {10.1016/j.ahj.2025.02.007}
}